3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 37.55
-1.60 (-4.09%)
Mar 9, 2026, 1:59 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.92 billion as of March 9, 2026. Its market cap has decreased by -41.05% in one year.
Market Cap
2.92B
Enterprise Value
2.24B
Revenue
324.87M
Ranking
n/a
PE Ratio
21.99
Stock Price
37.55
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 2.92B, an increase of 6.82%. That is a compound annual growth rate of 1.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syngen Biotech | 3.10B |
| Apex Biotechnology | 2.94B |
| SYN-TECH Chem. & Pharm. | 3.19B |
| Intech Biopharm | 3.38B |
| GlycoNex Incorporation | 2.71B |
| Shine-On BioMedical | 3.43B |
| BRIM Biotechnology | 3.44B |
| Sagittarius Life Science | 3.51B |